Roche to Launch New Test to Detect Covid-19 Antibodies
April 17 2020 - 1:57AM
Dow Jones News
By Mauro Orru
Roche Holding AG said Friday that it is developing a new
serology test to detect antibodies in patients who have been
exposed to the new coronavirus.
The Swiss drug maker said the Elecsys Anti-Sars-CoV-2
immunoassay is an in-vitro test to detect antibodies and assess the
body's immune reaction to Sars-CoV-2, better known as Covid-19,
using human serum and plasma from a blood sample.
Roche said the test would be available by early May for
countries under the European Union's CE mark, and that it is
working with the U.S. Food and Drug Administration for an emergency
use authorization.
The company said it is planning to ramp-up monthly production to
reach high double-digit million tests by June.
"The antibody test is an important next step in the fight
against Covid-19. Roche's antibody test can be quickly scaled and
made broadly available around the world as our instrument
infrastructure is already in place," said Thomas Schinecker, Chief
Executive for Roche Diagnostics.
Write to Mauro Orru at mauro.orru@wsj.com; @MauroOrru94
(END) Dow Jones Newswires
April 17, 2020 01:42 ET (05:42 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Apr 2023 to Apr 2024
